Adaptimmune Therapeutics PLC (ADAP)
0.634
-0.03
(-4.62%)
USD |
NASDAQ |
Nov 21, 16:00
0.634
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Price to Book Value: 2.028 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.126 |
| November 19, 2024 | 2.159 |
| November 18, 2024 | 1.903 |
| November 15, 2024 | 1.876 |
| November 14, 2024 | 1.891 |
| November 13, 2024 | 2.465 |
| November 12, 2024 | 2.539 |
| November 11, 2024 | 2.636 |
| November 08, 2024 | 2.549 |
| November 07, 2024 | 2.485 |
| November 06, 2024 | 2.646 |
| November 05, 2024 | 2.654 |
| November 04, 2024 | 2.646 |
| November 01, 2024 | 2.558 |
| October 31, 2024 | 2.321 |
| October 30, 2024 | 2.228 |
| October 29, 2024 | 2.253 |
| October 28, 2024 | 2.358 |
| October 25, 2024 | 2.359 |
| October 24, 2024 | 2.399 |
| October 23, 2024 | 2.510 |
| October 22, 2024 | 2.590 |
| October 21, 2024 | 2.635 |
| October 18, 2024 | 2.695 |
| October 17, 2024 | 2.691 |
| Date | Value |
|---|---|
| October 16, 2024 | 2.786 |
| October 15, 2024 | 2.814 |
| October 14, 2024 | 2.812 |
| October 11, 2024 | 2.788 |
| October 10, 2024 | 2.811 |
| October 09, 2024 | 2.845 |
| October 08, 2024 | 2.906 |
| October 07, 2024 | 2.910 |
| October 04, 2024 | 3.041 |
| October 03, 2024 | 2.862 |
| October 02, 2024 | 2.797 |
| October 01, 2024 | 2.947 |
| September 30, 2024 | 3.040 |
| September 27, 2024 | 2.596 |
| September 26, 2024 | 2.489 |
| September 25, 2024 | 2.442 |
| September 24, 2024 | 2.579 |
| September 23, 2024 | 2.492 |
| September 20, 2024 | 2.646 |
| September 19, 2024 | 2.683 |
| September 18, 2024 | 2.763 |
| September 17, 2024 | 2.789 |
| September 16, 2024 | 2.789 |
| September 13, 2024 | 2.949 |
| September 12, 2024 | 2.922 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.595
Minimum
Nov 22 2019
15.41
Maximum
Apr 01 2024
3.220
Average
2.540
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals PLC | 0.2294 |
| NuCana PLC | 0.5936 |
| Autolus Therapeutics PLC | 1.582 |
| Bicycle Therapeutics PLC | 1.686 |
| TC BioPharm (Holdings) PLC | 0.2284 |
Price to Book Value Related Metrics
| PS Ratio | 0.8918 |
| Price | 0.634 |
| Earnings Yield | -28.39% |
| Market Cap | 162.23M |